CASI PHARMACEUTICALS INC (CASI)       1.99  +0.08 (+4.19%)

1.99  +0.08 (+4.19%)

US14757U2087 - Common Stock

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -0.38 -0.47 0.0919.59% Q2 2022 -0.56 -0.65 0.0914.22% Q1 2022 -0.60 -0.88 0.2832.13% Q4 2021 -0.40 -0.58 0.1830.80% Q3 2021 -0.70 -0.56 -0.14-24.78% Q2 2021 -0.50 -0.74 0.2432.39% Q1 2021 -1.10 -0.61 -0.49-79.74% Q4 2020 -1.20 -0.71 -0.49-68.07%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -1.44 -2.70 46.54%Q4 2022 -0.30 -0.40 26.05%FY 2023 -0.91 -1.44 36.63%Q1 2023 -0.25 -0.60 58.35%Q2 2023 -0.26 -0.56 53.55%Q3 2023 -0.26 -0.38 32.89%Q4 2023 0.03 -0.30 110.34%FY 2024 -0.28 -0.91 69.52%FY 2025 -0.42 -0.28 -50.07%FY 2026 -0.64 -0.42 -53.07%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 10.213M 10.098M 115K1.14% Q2 2022 8.573M 8.033M 540K6.72% Q1 2022 9.062M 9.418M -356K-3.78% Q4 2021 9.158M 9.248M -90K-0.97% Q3 2021 8.112M 7.689M 423K5.50% Q2 2021 7.162M 6.14M 1.022M16.64% Q1 2021 5.74M 5.151M 589K11.43% Q4 2020 4.82M 4.538M 282K6.21%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 40.834M 30.168M 35.36%Q4 2022 12.784M 9.158M 39.59%FY 2023 62.016M 40.834M 51.87%Q1 2023 12.393M 9.062M 36.76%Q2 2023 13.209M 8.573M 54.08%Q3 2023 14.025M 10.213M 37.32%Q4 2023 29.478M 12.784M 130.59%FY 2024 104.46M 62.016M 68.44%FY 2025 148.63M 104.46M 42.28%FY 2026 182.16M 148.63M 22.56%